# Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/paclitaxel-plus-platinum-based-chemotherapy-versus-conventional-platinum-based/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mahesh Parmar,Jonathan A. Ledermann,Nicoletta Colombo,Andreas du Bois,Delaloye Jf,Gunnar B. Kristensen,Sarah Wheeler,Ann Marie Swart,W. Qian,Valter Torri,Irene Floriani,Gordon C. Jayson,Alan Lamont,C. Tropé |
| Citations | 1,204 |
| DOI | 10.1016/s0140-6736(03)13718-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2151050516 |
| PMID | 12826431 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.